SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-214459
Filing Date
2011-08-08
Accepted
2011-08-08 17:11:14
Documents
13
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 633259
2 MODIFICATION TO CONTRACT dex101.htm EX-10.1 79204
3 STOCK OPTION GRANT dex103.htm EX-10.3 21139
4 SEPARATION AND LEASE AGREEMENT dex104.htm EX-10.4 59866
5 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex311.htm EX-31.1 7124
6 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex312.htm EX-31.2 7067
7 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 4640
8 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 4582
  Complete submission text file 0001193125-11-214459.txt   2339134

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT avii-20110630.xml EX-101.INS 261191
10 XBRL TAXONOMY EXTENSION SCHEMA avii-20110630.xsd EX-101.SCH 14278
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avii-20110630_cal.xml EX-101.CAL 30931
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE avii-20110630_lab.xml EX-101.LAB 114203
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avii-20110630_pre.xml EX-101.PRE 73895
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 111018007
SIC: 2834 Pharmaceutical Preparations